ADAMTS13 and myocardial ischemia: Studies in cerebral and myocardial ischemia/reperfusion injury demonstrated larger infarct sizes and increased infiltration of neutrophils and pro-inflammatory cytokines in ADAMTS13-deficient mice, effects that were attenuated by recombinant ADAMTS13 administration [38,39,40].